The aim of this study was to investigate the inducible clindamycin resistance in 306 strains of staphylococci, isolated from various clinical samples over a period of two years. 
INTRODUCTION

Staphylococcus
aureus and coagulase-negative staphylococci (CoNS) are recognized as causing nosocomial and community-acquired infections worldwide. Infections due to staphylococci, especially methicilline resistant S. aureus (MRSA) are increasing among in-patient clinics and treatment of these infections pose difficulties (Maltezou et al., 2006; Manian et al., 2003) . Recently, MRSA has been isolated in more than 50% of nosocomial infections in USA (Manian et al., 2003) . In European countries this ratio has been reported as 30% in aaverage (18% in Switzerland, 19.3% in Spain, 54.4% in Portugal) (Munoz et al., 2002) . MRSA infection ratios differ between 9 and 40% in studies conducted in *Corresponding author. E-mail: drtgunduz@yahoo.com. Tel: +090 236 2371378 or +090 536 3398688. Fax: +090 236 2320058 Abbreviation: MRSA, methicilline resistant S. aureus; MSSA, methicillin sensitive S. aureus; MSCONS, methicillin sensitive coagulase-negative staphylococci; MRCoNS, methicillin resistant coagulase-negative staphylococci.
Turkey (Karadenizli, 2002; Al et al., 2008) .
Macrolides, lincosamides and streptogramin (MLS) antibiotics are used in the treatment of staphylococcal infections. Macrolide (MLS B ) resistance is the most common and clinically important mechanism of resistance encountered with Gram-positive organisms. MLS antibiotics are structurally unrelated, but micro-biologically related antibiotics because of their similar mode of action. Resistance may be constitutive ( c MLS B phenotype) or inducible ( i MLS B phenotype). The i MLS B phenotypes are not differentiated by using standard susceptibility test methods, but can be distinguished by erythromycinclindamycin disc approximation test (D-test) and demonstration of resistance genes by molecular methods (Sesli et al., 2008; Colakoğlu, 2008; Dinç et al., 2009; Pal et al., 2010; Gatermann et al., 2007) .
Resistance to MLS antibiotics occurs either through target site modification, efflux of antibiotics or drug modification (Leclercq, 2002) . MLS antibiotics inhibit bacterial protein synthesis by binding to 23s rRNA, which is a part of the large ribosomal subunit.
In target site modification methylation of the A2058 residue, located in the conserved domain V of 23s rRNA (Leclercq, 2002; Weisblum, 1995; Roberts et al., 1999; Asaka et al., 2003; Ciraj et al., 2009 ). Expression of MLS B phenotype can be constitutive (cMLS B ) or inducible (iMLS B ). Inducible resistance is observed when the inactive mRNA produced for the production of methylases, become active in the presence of an inducer, where as active methylase mRNA is produced in strains where constitutive expression is seen (Leclercq, 2002; Roberts et al., 1999; Asaka et al., 2003) .
Clindamycin is used commonly in the treatment of infections caused by MRSA. Good oral absorption makes this drug an important option in outpatient therapy or as a follow-up after intravenous therapy (Asaka et al.2003; Tong et al., 2011) .
But, treatment of an infection using clindamycin or any non inducer macrolide, caused by a strain carrying inducible erm gene, can lead to clinical failure (Ciraj et al., 2009; Siberry et al., 2003) . Constitutive mutants can be selected in vitro, in the presence of clindamycin or any other non inducer macrolide, as they are widespread among methicillin resistant strains (Leclercq, 2002; Ciraj et al., 2009) .
Although D-test is well recognized and applied for clinical test laboratories in some countries, this is not the case for Turkey. That's why inducible type resistance in our region is not well known.
The present study was designed to detect the presence of inducible clindamycin resistance, among the clinical isolates of staphylococci.
MATERIALS AND METHODS
306 strains of staphylococci, isolated from various clinical samples (urine, pus, blood, sputulum vs.) over a period of two years at the Department of Microbiology, State Hospital, Manisa. All the Staphylococcal spp. were identified by conventional microbiological methods including colony morphology, Gram stain, catalase, slide coagulase and tube coagulase.
All isolates were initially screened for erythromycin resistance using the Kirby Bauer method. The isolates that were found to be erythromycin resistant were examined for inducible clindamycin resistance (iMLSB) by using double disc approximation test (D-test) at 15 mm disk separation. Briefly, an erythromycin disc was placed 15 to 26 mm (edge to edge) from a clindamycin disc in a standard disc diffusion test. A flattening of the zone of inhibition in the area between the discs where both drugs have diffused after 18 to 24 h of incubation was considered as inducible clindamycin resistance (Kloos et al., 1999; Clinical and Laboratory Standards Institute., 2008; Dizbay et al., 2008) . Antibiotic susceptibility testing was performed by Kirby Bauer disc diffusion method. Erythromycin (15 µg) and clindamycin (2 µg) discs were procured from Bioanalyse Limited in Turkey.
Inducible clindamycin resistance (iMLSB) is defined by flattening of erythromycin side of the inhibition zone of clindamycin disc (D zone formation). Strains that do not form inhibition zone around clindamycin and erythromycin discs are accepted as resistant structurally (constitutive) to MLSB antibiotics (cMLSB) (Leclercq, 2002; Weisblum, 1995; Dizbay et al., 2008 
RESULTS
Out of the 306 isolates 177 (57.8%) were S. aureus and 129 (42.2 %) were coagulase negative staphylococci. Sources and categorization of staphylococcal isolates are shown in Table 1 .
Out of 177 S.aureus strains 53 (17.3%) were MRSA and 124 (40.5 %) were methicillin sensitive S. aureus (MSSA). Among the coagulase negative staphylococci, 121 (39.6%) were methicillin sensitive and 8 (2.6%) were methicillin resistant.
Out of the 306 clinical isolates 99 (36.4%) showed erythromycin resistance. Among the erythromycin resistant isolates 53 (53.5%) were S. aureus of which 37 (37.3%) were MRSA and 16 (16.2%) MSSA. Among the erythromycin resistant isolates 46 (46.5%) were CoNS of which 8 (15.1%) were MRCoNS and 38 (31.4%) MSCoNS. The greatest prevalence of resistance of MRSA was seen for erythromycin (69.8%), and clindamycin (30.2%) ( Table 2) .
Thirty-one erythromycin resistant isolates 20 (6.5% of the total isolates) belonged to MLSBi phenotype, showing inducible clindamycin resistance (Figure 1 ). Among them 13 isolates were MRSA (4.2% of the total MRSA), six were MSSA (2.0% of total MSSA) and nine isolates were CONS (3.0% of total CoNS). Eleven isolates to MLSBc phenotype, showed constitutive resistance to Sample  MRSA  MSSA  MRCONS  MSCONS  Total  Urine  4  2  5  -11  Pus  12  3  3  1  19  Blood  -1  --1  Catheter  ----Sputulum  -----Total  16  6  8  1  31 clindamycin, of which three were MRSA and eight belonged to methicillin resistant coagulase negative staphylococci (MRCoNS). Distribution of resistance phenotypes of the isolates are shown in Table 3 .
Also, MRSA isolates showed both higher inducible resistance and constitutive resistance to clindamycin as compared to Methicillin-sensitive Staphylococcus aureus (p > 0.05). Erythromycin resistant and clindamycin sensitive strains that didn't show inducible resistance (MS phenotype) were not detected in this study. Showing no strains were isolated.
DISCUSSION
MRSA strains that cause hospital or community based serious infections may cause problems in treatment. MRSA prevalence has been reported to vary between 9 and 54.6% in hospital based infections (Manian et al., 2003; Karadenizli, 2002; Al et al. 2008; Orret and Land, 2006) . We found this rate as 17.3% in the present study. Drug selection is important in the treatment of MRSA infections.
Determination of resistance to MLS antibiotics will be beneficial in selecting the appropriate treatment for MRSA infections. Inducible resistance occurs in the presence of strong of methylase inducers like macrolide antibiotics such as erythromycin or azithromycin. MLS B resistant strains are seen sensitive falsely in the presence of weak inducers like spiramisin, clindamycin and quinupristin (Fiebelkorn et al., 2003; Spiliopoulou et al., 2004; Steward et al., 2005) .
Clindamycin is commonly used in the treatment of erythromycin resistant S. aureus causing skin and soft tissue infections (Deotale et al., 2010) . Recently, Clinical failure of clindamycin therapy has been reported (Ciraj et al., 2009) .
If MLS B resistance is not evaluated false sensitivity to clindamycin will be determined and this may lead to treatment failure (Ciraj et al., 2009; Siberry et al., 2003) . A major concern with regard to the use of clindamycin for staphylococcal infections is the possible presence of inducible resistance to clindamycin (Al et al.2008) .
MLS B resistance in MRSA strains have been reported as iMLS B 7 to 38.7% and cMLS B 29.7 to 97% (Fiebelkorn et al., 2003; Spiliopoulou et al., 2004; Schmitz et al., 2000; Otsuka et al., 2007) in various countries. In studies from Turkey iMLSB has been reported as 20.6 to 76.5% and cMLSB has been reported as 50.8 to 64.6% Colakoğlu, 2008; Dizbay et al., 2008; Azap et al., 2005; Delialioglu et al., 2005) .
In our study, 35.1% of strains were iMLS B phenotype and 8.1% were cMLS B phenotype among the MRSA strains. Results with regard to the MSSA strains is similar to the previous studies where no constitutive resistance was reported and inducible resistance to clindamycin was approximately 11% (Ciraj et al., 2009; Delialioglu et al., 2005) .
The emergence of resistance to multiple antibiotics among staphylococci strains has left very few therapeutic options for clinicians. Though 50% of our isolates were resistant phenotypes, the other 50% were sensitive to clindamycin, against which it would be safe and appropriate to use clindamycin or other macrolides. Therefore, using in vitro erythromycin resistance as a surrogate marker for all the MLS antibiotics, and thereby avoiding them as a treatment option, would be inappropriate. A therapeutic decision is not possible without the relevant antibiotic susceptibility data. This is where the D test becomes significant (Ciraj et al., 2009) .
The D-test is an easy test to perform along with the routine susceptibility testing.
Inducible clindamycin resistance is helpful in guiding the anti staphylococcal therapy. Therefore, we recommend that MLS antibiotics should be included the D-test for inducible resistance to clindamycin in the routine antibiotic susceptibility testing.
